{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:16:33Z","timestamp":1780359393831,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515111191"],"award-info":[{"award-number":["2022A1515111191"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010652"],"award-info":[{"award-number":["2022A1515010652"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515012270"],"award-info":[{"award-number":["2021A1515012270"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515011379"],"award-info":[{"award-number":["2021A1515011379"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304975"],"award-info":[{"award-number":["82304975"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271849"],"award-info":[{"award-number":["82271849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170767"],"award-info":[{"award-number":["82170767"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001727"],"award-info":[{"award-number":["82001727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"high-level talent introduction supporting scientific research funds of Guangdong Provincial People's Hospital","award":["KY012021441"],"award-info":[{"award-number":["KY012021441"]}]},{"name":"Science and Technology Project of Guangzhou City","award":["202102010341"],"award-info":[{"award-number":["202102010341"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12272-024-01505-1","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T18:02:46Z","timestamp":1720461766000},"page":"632-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment"],"prefix":"10.1007","volume":"47","author":[{"given":"Xiaoyi","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","volume":"2","author":"AH Andreotti","year":"2010","unstructured":"Andreotti AH, Schwartzberg PL, Joseph RE, Berg LJ (2010) T-cell signaling regulated by the Tec family kinase. Itk Cold Spring Harb Perspect Biol 2:a002287. https:\/\/doi.org\/10.1101\/cshperspect.a002287","journal-title":"Itk Cold Spring Harb Perspect Biol"},{"key":"1505_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1146\/annurev-immunol-042617-053344","volume":"36","author":"AH Andreotti","year":"2018","unstructured":"Andreotti AH, Joseph RE, Conley JM, Iwasa J, Berg LJ (2018) Multidomain control over TEC kinase activation state tunes the T cell response. Annu Rev Immunol 36:549\u2013578. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053344","journal-title":"Annu Rev Immunol"},{"key":"1505_CR3","doi-asserted-by":"publisher","first-page":"102873","DOI":"10.1016\/j.jaut.2022.102873","volume":"132","author":"L Arbitman","year":"2022","unstructured":"Arbitman L, Furie R, Vashistha H (2022) B cell-targeted therapies in systemic lupus erythematosus. J Autoimmun 132:102873. https:\/\/doi.org\/10.1016\/j.jaut.2022.102873","journal-title":"J Autoimmun"},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/TCRM.S252592","volume":"17","author":"A Bag-Ozbek","year":"2021","unstructured":"Bag-Ozbek A, Hui-Yuen JS (2021) Emerging B-Cell therapies in systemic lupus erythematosus. Ther Clin Risk Manag 17:39\u201354. https:\/\/doi.org\/10.2147\/TCRM.S252592","journal-title":"Ther Clin Risk Manag"},{"key":"1505_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4049\/jimmunol.1302570","volume":"193","author":"MJ Benson","year":"2014","unstructured":"Benson MJ, Rodriguez V, von Schack D, Keegan S, Cook TA, Edmonds J, Benoit S, Seth N, Du S, Messing D, Nickerson-Nutter CL, Dunussi-Joannopoulos K, Rankin AL, Ruzek M, Schnute ME, Douhan J 3rd (2014) Modeling the clinical phenotype of BTK inhibition in the mature murine immune system. J Immunol 193:185\u2013197. https:\/\/doi.org\/10.4049\/jimmunol.1302570","journal-title":"J Immunol"},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/cr.2010.182","volume":"21","author":"M Blonska","year":"2011","unstructured":"Blonska M, Lin X (2011) NF-\u03baB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res 21:55\u201370. https:\/\/doi.org\/10.1038\/cr.2010.182","journal-title":"Cell Res"},{"key":"1505_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","volume":"41","author":"S Caielli","year":"2023","unstructured":"Caielli S, Wan Z, Pascual V (2023) Systemic lupus erythematosus pathogenesis: interferon and beyond. Annu Rev Immunol 41:533\u2013560. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-042422","journal-title":"Annu Rev Immunol"},{"key":"1505_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/14728214.2020.1822817","volume":"25","author":"E Carnero Contentti","year":"2020","unstructured":"Carnero Contentti E, Correale J (2020) Bruton\u2019s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis. Expert Opin Emerg Drugs 25:377\u2013381. https:\/\/doi.org\/10.1080\/14728214.2020.1822817","journal-title":"Expert Opin Emerg Drugs"},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/med.21842","volume":"41","author":"T Efferth","year":"2021","unstructured":"Efferth T, Oesch F (2021) The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases. Med Res Rev 41:3023\u20133061. https:\/\/doi.org\/10.1002\/med.21842","journal-title":"Med Res Rev"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","volume":"19","author":"S Fasano","year":"2023","unstructured":"Fasano S, Milone A, Nicoletti GF, Isenberg DA, Ciccia F (2023) Precision medicine in systemic lupus erythematosus. Nat Rev Rheumatol 19:331\u2013342. https:\/\/doi.org\/10.1038\/s41584-023-00948-y","journal-title":"Nat Rev Rheumatol"},{"key":"1505_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cden.2013.06.003","volume":"57","author":"G Fortuna","year":"2013","unstructured":"Fortuna G, Brennan MT (2013) Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management. Dent Clin North Am 57:631\u2013655. https:\/\/doi.org\/10.1016\/j.cden.2013.06.003","journal-title":"Dent Clin North Am"},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3389\/fimmu.2018.01637","volume":"9","author":"N Gensous","year":"2018","unstructured":"Gensous N, Charrier M, Duluc D, Contin-Bordes C, Truchetet ME, Lazaro E, Duffau P, Blanco P, Richez C (2018) T Follicular helper cells in autoimmune disorders. Front Immunol 9:1637. https:\/\/doi.org\/10.3389\/fimmu.2018.01637","journal-title":"Front Immunol"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fimmu.2018.00979","volume":"9","author":"S Ghosh","year":"2018","unstructured":"Ghosh S, Drexler I, Bhatia S, Adler H, Gennery AR, Borkhardt A (2018) Interleukin-2-inducible T-cell kinase deficiency-new patients, new insight? Front Immunol 9:979. https:\/\/doi.org\/10.3389\/fimmu.2018.00979","journal-title":"Front Immunol"},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/BOR.0000000000000922","volume":"35","author":"E G\u00f3mez-Ba\u00f1uelos","year":"2023","unstructured":"G\u00f3mez-Ba\u00f1uelos E, Fava A, Andrade F (2023) An update on autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 35:61\u201367. https:\/\/doi.org\/10.1097\/BOR.0000000000000922","journal-title":"Curr Opin Rheumatol"},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"297868","DOI":"10.1155\/2011\/297868","volume":"2011","author":"JA Grasis","year":"2011","unstructured":"Grasis JA, Tsoukas CD (2011) Itk: the rheostat of the T cell response. J Signal Transduct 2011:297868. https:\/\/doi.org\/10.1155\/2011\/297868","journal-title":"J Signal Transduct"},{"key":"1505_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","volume":"142","author":"WE Ho","year":"2014","unstructured":"Ho WE, Peh HY, Chan TK, Wong WS (2014) Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther 142:126\u2013139. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.12.001","journal-title":"Pharmacol Ther"},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev.immunol.021908.132550","volume":"28","author":"PG Hogan","year":"2010","unstructured":"Hogan PG, Lewis RS, Rao A (2010) Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol 28:491\u2013533. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132550","journal-title":"Annu Rev Immunol"},{"key":"1505_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2016.00520","volume":"7","author":"GM Jogdand","year":"2016","unstructured":"Jogdand GM, Mohanty S, Devadas S (2016) Regulators of Tfh cell differentiation. Front Immunol 7:520. https:\/\/doi.org\/10.3389\/fimmu.2016.00520","journal-title":"Front Immunol"},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4049\/jimmunol.181.1.288","volume":"181","author":"J Jongstra-Bilen","year":"2008","unstructured":"Jongstra-Bilen J, Puig Cano A, Hasija M, Xiao H, Smith CI, Cybulsky MI (2008) Dual functions of Bruton\u2019s tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis. J Immunol 181:288\u2013298. https:\/\/doi.org\/10.4049\/jimmunol.181.1.288","journal-title":"J Immunol"},{"key":"1505_CR20","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.biocel.2012.08.023","volume":"44","author":"A Kannan","year":"2012","unstructured":"Kannan A, Huang W, Huang F, August A (2012) Signal transduction via the T cell antigen receptor in na\u00efve and effector\/memory T cells. Int J Biochem Cell Biol 44:2129\u20132134. https:\/\/doi.org\/10.1016\/j.biocel.2012.08.023","journal-title":"Int J Biochem Cell Biol"},{"key":"1505_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ejps.2012.07.013","volume":"47","author":"M Kaur","year":"2012","unstructured":"Kaur M, Bahia MS, Silakari O (2012) Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions. Eur J Pharm Sci 47:574\u2013588. https:\/\/doi.org\/10.1016\/j.ejps.2012.07.013","journal-title":"Eur J Pharm Sci"},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3389\/fimmu.2018.01793","volume":"9","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Lee K, Diamond B (2018) Follicular helper T Cells in systemic lupus erythematosus. Front Immunol 9:1793. https:\/\/doi.org\/10.3389\/fimmu.2018.01793","journal-title":"Front Immunol"},{"key":"1505_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"DL Klayman","year":"1985","unstructured":"Klayman DL (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science 228:1049\u20131055. https:\/\/doi.org\/10.1126\/science.3887571","journal-title":"Science"},{"key":"1505_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","volume":"74","author":"S Lazar","year":"2023","unstructured":"Lazar S, Kahlenberg JM (2023) Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med 74:339\u2013352. https:\/\/doi.org\/10.1146\/annurev-med-043021-032611","journal-title":"Annu Rev Med"},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.intimp.2013.03.011","volume":"16","author":"T Li","year":"2013","unstructured":"Li T, Chen H, Yang Z, Liu XG, Zhang LM, Wang H (2013) Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo. Int Immunopharmacol 16:306\u2013312. https:\/\/doi.org\/10.1016\/j.intimp.2013.03.011","journal-title":"Int Immunopharmacol"},{"key":"1505_CR26","doi-asserted-by":"publisher","first-page":"102861","DOI":"10.1016\/j.jaut.2022.102861","volume":"132","author":"H Lou","year":"2022","unstructured":"Lou H, Ling GS, Cao X (2022) Autoantibodies in systemic lupus erythematosus: from immunopathology to therapeutic target. J Autoimmun 132:102861. https:\/\/doi.org\/10.1016\/j.jaut.2022.102861","journal-title":"J Autoimmun"},{"key":"1505_CR27","first-page":"6","volume":"69","author":"H Mano","year":"1999","unstructured":"Mano H (1999) The Tec family protein-tyrosine kinases: a subset of kinases for a subset of signalings. Int J Hematol 69:6\u201312","journal-title":"Int J Hematol"},{"key":"1505_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","volume":"17","author":"S Pal Singh","year":"2018","unstructured":"Pal Singh S, Dammeijer F, Hendriks RW (2018) Role of Bruton\u2019s tyrosine kinase in B cells and malignancies. Mol Cancer 17:57. https:\/\/doi.org\/10.1186\/s12943-018-0779-z","journal-title":"Mol Cancer"},{"key":"1505_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fimmu.2019.00095","volume":"10","author":"J Rip","year":"2019","unstructured":"Rip J, de Bruijn MJW, Appelman MK, Pal Singh S, Hendriks RW, Corneth OBJ (2019) Toll-Like receptor signaling drives Btk-mediated autoimmune disease. Front Immunol 10:95. https:\/\/doi.org\/10.3389\/fimmu.2019.00095","journal-title":"Front Immunol"},{"key":"1505_CR30","doi-asserted-by":"publisher","first-page":"690","DOI":"10.2174\/156802609789044443","volume":"9","author":"N Sahu","year":"2009","unstructured":"Sahu N, August A (2009) ITK inhibitors in inflammation and immune-mediated disorders. Curr Top Med Chem 9:690\u2013703. https:\/\/doi.org\/10.2174\/156802609789044443","journal-title":"Curr Top Med Chem"},{"key":"1505_CR31","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.192.11.1553","volume":"192","author":"P Schaerli","year":"2000","unstructured":"Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B (2000) CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 192:1553\u20131562. https:\/\/doi.org\/10.1084\/jem.192.11.1553","journal-title":"J Exp Med"},{"key":"1505_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11892-016-0770-2","volume":"16","author":"MG Scherm","year":"2016","unstructured":"Scherm MG, Ott VB, Daniel C (2016) Follicular helper T cells in autoimmunity. Curr Diab Rep 16:75. https:\/\/doi.org\/10.1007\/s11892-016-0770-2","journal-title":"Curr Diab Rep"},{"key":"1505_CR33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","volume":"27","author":"JE Smith-Garvin","year":"2009","unstructured":"Smith-Garvin JE, Koretzky GA, Jordan MS (2009) T cell activation. Annu Rev Immunol 27:591\u2013619c. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132706","journal-title":"Annu Rev Immunol"},{"key":"1505_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/BOR.0000000000000480","volume":"30","author":"G Stojan","year":"2018","unstructured":"Stojan G, Petri M (2018) Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol 30:144\u2013150. https:\/\/doi.org\/10.1097\/BOR.0000000000000480","journal-title":"Curr Opin Rheumatol"},{"key":"1505_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.55563\/clinexprheumatol\/7gzsxp","volume":"39","author":"F Trentin","year":"2021","unstructured":"Trentin F, Zucchi D, Signorini V, Elefante E, Bortoluzzi A, Tani C (2021) One year in review 2021: systemic lupus erythematosus. Clin Exp Rheumatol 39:231\u2013241. https:\/\/doi.org\/10.55563\/clinexprheumatol\/7gzsxp","journal-title":"Clin Exp Rheumatol"},{"key":"1505_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa CG, Linterman MA, Yu D, MacLennan IC (2016) Follicular helper T cells. Annu Rev Immunol 34:335\u2013368. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055605","journal-title":"Annu Rev Immunol"},{"key":"1505_CR37","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.celrep.2015.05.022","volume":"11","author":"MT Wong","year":"2015","unstructured":"Wong MT, Chen J, Narayanan S, Lin W, Anicete R, Kiaang HT, De Lafaille MA, Poidinger M, Newell EW (2015) Mapping the diversity of follicular helper T cells in human blood and tonsils using high-dimensional mass cytometry analysis. Cell Rep 11:1822\u20131833. https:\/\/doi.org\/10.1016\/j.celrep.2015.05.022","journal-title":"Cell Rep"},{"key":"1505_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/cmi.2015.13","volume":"13","author":"Y Wu","year":"2016","unstructured":"Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z, Yang X, Zhu F, He P, Tang W, Zuo J (2016) Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL\/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation. Cell Mol Immunol 13:379\u2013390. https:\/\/doi.org\/10.1038\/cmi.2015.13","journal-title":"Cell Mol Immunol"},{"key":"1505_CR39","doi-asserted-by":"publisher","first-page":"109181","DOI":"10.1016\/j.biopha.2019.109181","volume":"117","author":"X Yuan","year":"2019","unstructured":"Yuan X, Li J, Li Y, Deng Z, Zhou L, Long J, Tang Y, Zuo Z, Zhang Y, Xie H (2019) Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea. Biomed Pharmacother 117:109181. https:\/\/doi.org\/10.1016\/j.biopha.2019.109181","journal-title":"Biomed Pharmacother"},{"key":"1505_CR40","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.4049\/jimmunol.1200919","volume":"189","author":"YG Zhao","year":"2012","unstructured":"Zhao YG, Wang Y, Guo Z, Gu AD, Dan HC, Baldwin AS, Hao W, Wan YY (2012) Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway. J Immunol 189:4417\u20134425. https:\/\/doi.org\/10.4049\/jimmunol.1200919","journal-title":"J Immunol"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-024-01505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-024-01505-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-024-01505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T15:17:11Z","timestamp":1722957431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-024-01505-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1007\/s12272-024-01505-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}